Tara Lin Couch Archives - EAS Consulting Group

Tara Couch Discusses FDA Enforcement of Dietary Supplements in RAPS Regulatory Focus

Jul 19, 2021 | Dietary Supplements, EAS in the News Dietary Supplements

The pandemic has resulted in an increase in the number of misbranded dietary supplements. As a result, FDA is using updated, alternative, and remote enforcement tools to ensure compliance. Tara Couch, Senior Director for dietary supplement and tobacco services covers...

EAS Senior Director Tara Lin Couch, Ph.D. Featured in NCIA Podcast on the Future of Cannabis Consumerism

Feb 22, 2021 | Cannabis, EAS in Action

EAS Senior Director for Dietary Supplement and Tobacco Services, Tara Lin Couch, Ph.D. was interviewed for the National Cannabis Business Industry’s podcast on the future of cannabis consumerism. Listen now on Apple podcast and Stitcher and hear more about the...

How to Perform an OOS Investigation for Tablets and Capsules magazine

Aug 1, 2020 | Dietary Supplements, EAS in Action, EAS in the News Dietary Supplements

Senior Director for Dietary Supplements and Tobacco Services, Tara Lin Couch, Ph.D. authored an article on How to Perform an OOS Investigation for Tablets and Capsules magazine. EAS is a recognized industry leader for regulatory services to the dietary supplement...

Qualifying Suppliers – Dietary Supplements FSVP Requirements in the Era of COVID-19

Apr 28, 2020 | Dietary Supplements, On Demand Webinar

The COVID-19 pandemic is causing major disruptions of business and the global supply chain across many industries including public health products that are regulated by the FDA. This means there is an additional challenge for these …

Sayler and Couch Discuss Importing Challenges for Dietary Supplements Under FSMA and FSVP

Apr 1, 2020 | EAS in Action, EAS in the News Dietary Supplements

EAS Senior Directors Allen Sayler and Tara Couch, Ph.D. discussed importing challenges of dietary supplements, particularly in light of the Foreign Supplier Verification Program in Food Safety Magazine. Dietary supplement firms must comply with GMPs set forth in 21...